Mitochondria and the economy of stress (mal)adaptation

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 4, 2013, Pages 668-680

  Morava, Éva ^a   Kozicz, Tamás ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Depression; Exhaustion; Mitochondria; Neuronal plasticity; Stress

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; LITHIUM; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; SERTRALINE; VALPROIC ACID; VENLAFAXINE;

ADAPTATION; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN MITOCHONDRION; DEPRESSION; ENERGY; HUMAN; MALADJUSTMENT; MENTAL HEALTH; MITOCHONDRION FUNCTION; NERVE CELL PLASTICITY; NONHUMAN; PATHOGENESIS; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; REVIEW; STRESS;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; BRAIN; BRAIN CHEMISTRY; DEPRESSION; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; STRESS, PSYCHOLOGICAL;

EID: 84876300402     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.02.005     Document Type: Review

References (213)

1. Acosta G.B., Otero Losada M.E., Rubio M.C. Area-dependent changes in GABAergic function after acute and chronic cold stress. Neuroscience Letters 1993, 154(1-2):175-178.
2. Alcaro A., Panksepp J., Witczak J., Hayes D.J., Northoff G. Is subcortical-cortical midline activity in depression mediated by glutamate and GABA? A cross-species translational approach. Neuroscience and Biobehavioral Reviews 2010, 34(4):592-605.
3. Altar C.A., Jurata L.W., Charles V., Lemire A., Liu P., Bukhman Y., Young T.A., Bullard J., Yokoe H., Webster M.J., Knable M.B., Brockman J.A. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biological Psychiatry 2005, 58:85-96.
4. Andlin-Sobocki P., Wittchen H.U. Cost of affective disorders in Europe. European Journal of Neurology 2005, 12(Suppl. 1):34-38.
5. Anglin R.E., Garside S.L., Tarnopolsky M.A., Mazurek M.F., Rosebush P.I. The psychiatric manifestations of mitochondrial disorders: a case and review of the literature. Journal of Clinical Psychiatry 2012, 73(4):506-512.
6. Arato M., Banki C.M., Bissette G., Nemeroff C.B. Elevated CSF CRF in suicide victims. Biological Psychiatry 1989, 25:355-359.
7. Bagosi Z., Csabafi K., Jaszberenyi M., Telegdy G. The effects of corticotropin-releasing factor and the urocortins on hypothalamic gamma-amino butyric acid release-the impacts on the hypothalamic-pituitary-adrenal axis. Neurochemistry International 2012, 60(4):350-354.
8. Baldwin D.S., Papakostas G.I. Symptoms of fatigue and sleepiness in major depressive disorder. Journal of Clinical Psychiatry 2006, 67(Suppl. 6):9-15.
9. Bale T.L. Stress sensitivity and the development of affective disorders. Hormones and Behavior 2006, 50:529-533.
10. Bale T.L., Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annual Review of Pharmacology and Toxicology 2004, 44:525-557.
11. Banki C.M., Bissette G., Arato M., O'Connor L., Nemeroff C.B. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. American Journal of Psychiatry 1987, 144:873-877.
12. Baxter L.R., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., Selin C.E., Gerner R.H., Sumida R.M. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry 1989, 46(3):243-250.
13. Becker C., Zeau B., Rivat C., Blugeot A., Hamon M., Benoliel J.J. Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin. Molecular Psychiatry 2008, 13:1079-1092.
14. Belmaker R.H., Agam G. Major depressive disorder. New England Journal of Medicine 2008, 358(1):55-68.
15. Ben-Shachar D., Karry R. Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS ONE 2008, 3(11):e3676.
16. Binder E.B., Nemeroff C.B. The CRF system, stress, depression and anxiety-insights from human genetic studies. Molecular Psychiatry 2010, 15(6):574-588.
17. Burdon R.H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radical Biology and Medicine 1995, 18(4):775-794.
18. Burkhardt C., Kelly J.P., Lim Y.H., Filley C.M., Parker W.D. Neuroleptic medications inhibit complex I of the electron transport chain. Annals of Neurology 1993, 33(5):512-517.
19. Cali T., Ottolini D., Brini M. Mitochondrial Ca(2+) as a key regulator of mitochondrial activities. Advances in Experimental Medicine and Biology 2012, 942:53-73.
20. Carrozzo R., Dionisi-Vici C., Steuerwald U., Lucioli S., Deodato F., Di G.S., Bertini E., Franke B., Kluijtmans L.A., Meschini M.C., Rizzo C., Piemonte F., Rodenburg R., Santer R., Santorelli F.M., van R.A., Vermunt-de K.D., Morava E., Wevers R.A. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 2007, 130(Pt 3):862-874.
21. Chen H., Chan D.C. Critical dependence of neurons on mitochondrial dynamics. Current Opinion in Cell Biology 2006, 18(4):453-459.
22. Chen H., Chan D.C. Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Human Molecular Genetics 2009, 18(R2):R169-R176.
23. Chen H., McCaffery J.M., Chan D.C. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 2007, 130(3):548-562.
24. Chen R.W., Chuang D.M. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. Journal of Biological Chemistry 1999, 274(10):6039-6042.
25. Cheng A., Hou Y., Mattson M.P. Mitochondria and neuroplasticity. ASN Neuro 2010, 2(5):e00045.
26. Cooke S.F., Bliss T.V. Plasticity in the human central nervous system. Brain 2006, 129(Pt 7):1659-1673.
27. Cree L.M., Samuels D.C., Chinnery P.F. The inheritance of pathogenic mitochondrial DNA mutations. Biochimica et Biophysica Acta 2009, 1792:1097-1102.
28. Cullinan W.E., Ziegler D.R., Herman J.P. Functional role of local GABAergic influences on the HPA axis. Brain Structure and Function 2008, 213(1-2):63-72.
29. Daley E., Wilkie D., Loesch A., Hargreaves I.P., Kendall D.A., Pilkington G.J., Bates T.E. Chlorimipramine: a novel anticancer agent with a mitochondrial target. Biochemical and Biophysical Research Communications 2005, 328(2):623-632.
30. Dallman M.F., Pecoraro N.C., La Fleur S.E., Warne J.P., Ginsberg A.B., Akana S.F., Laugero K.C., Houshyar H., Strack A.M., Bhatnagar S., Bell M.E. Glucocorticoids, chronic stress, and obesity. Progress in Brain Research 2006, 153:75-105.
31. Danzer S.C. Depression, stress, epilepsy and adult neurogenesis. Experimental Neurology 2012, 233(1):22-32.
32. Datson N.A., van der P.J., de Kloet E.R., Vreugdenhil E. Expression profile of 30,000 genes in rat hippocampus using SAGE. Hippocampus 2001, 11:430-444.
33. Davis A.F., Clayton D.A. In situ localization of mitochondrial DNA replication in intact mammalian cells. Journal of Cell Biology 1996, 135(4):883-893.
34. de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nature Reviews Neuroscience 2005, 6:463-475.
35. de Vries M.C., Rodenburg R.J., Morava E., van Kaauwen E.P., ter L.H., Mullaart R.A., Snoeck I.N., van Hasselt P.M., Harding P., van den Heuvel L.P., Smeitink J.A. Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations. European Journal of Pediatrics 2007, 166(3):229-234.
36. Deakin J. The role of serotonin in depression and anxiety. European Psychiatry 1998, 13(Suppl. 2):57s-63s.
37. Desquiret-Dumas V., Gueguen N., Barth M., Chevrollier A., Hancock S., Wallace D.C., Amati-Bonneau P., Henrion D., Bonneau D., Reynier P., Procaccio V. Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS. Biochimica et Biophysica Acta 2012, 1822(6):1019-1029.
38. DiMauro S., et al. Mitochondrial psychiatry. Mitochondrial Medicine 2001, Informa Healthcare, London, pp. 261-277.
39. DiMauro S., Rustin P. A critical approach to the therapy of mitochondrial respiratory chain and oxidative phosphorylation diseases. Biochimica et Biophysica Acta 2009, 1792:1159-1167.
40. DiMauro S., Schon E.A. Mitochondrial disorder in the nervous system. Annual Review of Neuroscience 2008, 31:91-123.
41. Ditzen C., Tang N., Jastorff A.M., Teplytska L., Yassouridis A., Maccarrone G., Uhr M., Bronisch T., Miller C.A., Holsboer F., Turck C.W. Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology. Neuropsychopharmacology 2012, 37(4):1013-1025.
42. Dubeau F., De S.N., Zifkin B.G., Arnold D.L., Shoubridge E.A. Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree. Annals of Neurology 2000, 47(2):179-185.
43. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biological Psychiatry 2006, 59:1116-1127.
44. Duman R.S., Voleti B. Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends in Neurosciences 2011.
45. Dumas T.C., Gillette T., Ferguson D., Hamilton K., Sapolsky R.M. Anti-glucocorticoid gene therapy reverses the impairing effects of elevated corticosterone on spatial memory, hippocampal neuronal excitability, and synaptic plasticity. Journal of Neuroscience 2010, 30(5):1712-1720.
46. Dykens J.A., Jamieson J.D., Marroquin L.D., Nadanaciva S., Xu J.J., Dunn M.C., Smith A.R., Will Y. In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone. Toxicological Sciences 2008, 103(2):335-345.
47. Elliott E., Ezra-Nevo G., Regev L., Neufeld-Cohen A., Chen A. Resilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice. Nature Neuroscience 2010, 13(11):1351-1353.
48. Even C., Weintraub D. Case for and against specificity of depression in Alzheimer's disease. Psychiatry and Clinical Neurosciences 2010, 64(4):358-366.
49. Fattal O., Link J., Quinn K., Cohen B.H., Franco K. Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectrums 2007, 12:429-438.
50. Feder A., Nestler E.J., Charney D.S. Psychobiology and molecular genetics of resilience. Nature Reviews Neuroscience 2009, 10(6):446-457.
51. Feinberg A.P. Epigenetics at the epicenter of modern medicine. Journal of the American Medical Association 2008, 299(11):1345-1350.
52. Finsterer J. Central nervous system manifestations of mitochondrial disorders. Acta Neurologica Scandinavica 2006, 114:217-238.
53. Flandreau E.I., Ressler K.J., Owens M.J., Nemeroff C.B. Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology 2011, [Epub ahead of print]; PMID: 21616602.
54. Gardner A., Boles R.G. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011, 35(3):730-743.
55. Gardner A., Johansson A., Wibom R., Nennesmo I., von Dobeln U., Hagenfeldt L., Hallstrom T. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. Journal of Affective Disorders 2003, 76:55-68.
56. Gardner A., Pagani M., Jacobsson H., Lindberg G., Larsson S.A., Wagner A., Hallstrom T. Differences in resting state regional cerebral blood flow assessed with 99mTc-HMPAO SPECT and brain atlas matching between depressed patients with and without tinnitus. Nuclear Medicine Communications 2002, 23(5):429-439.
57. Gardner A., Pagani M., Wibom R., Nennesmo I., Jacobsson H., Hallstrom T. Alterations of rCBF and mitochondrial dysfunction in major depressive disorder: a case report. Acta Psychiatrica Scandinavica 2003, 107:233-239.
58. Gelenberg A.J. Depression symptomatology and neurobiology. Journal of Clinical Psychiatry 2010, 71(1):e02.
59. 2+ in the regulation of cellular energetics. Biochemistry 2012, 51(14):2959-2973.
60. Gong Y., Chai Y., Ding J.H., Sun X.L., Hu G. Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain. Neuroscience Letters 2011, 488(1):76-80.
61. Goodwin G.M. Depression and associated physical diseases and symptoms. Dialogues in Clinical Neuroscience 2006, 8:259-265.
62. Graeff F.G., Guimaraes F.S., De Andrade T.G., Deakin J.F. Role of 5-HT in stress, anxiety, and depression. Pharmacology Biochemistry and Behavior 1996, 54(1):129-141.
63. Gronli J., Fiske E., Murison R., Bjorvatn B., Sorensen E., Ursin R., Portas C.M. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behavioural Brain Research 2007, 181(1):42-51.
64. Halliwell B. Reactive oxygen species and the central nervous system. Journal of Neurochemistry 1992, 59(5):1609-1623.
65. Hasler G., Northoff G. Discovering imaging endophenotypes for major depression. Molecular Psychiatry 2011, 16(6):604-619.
66. Hasler G., van der Veen J.W., Grillon C., Drevets W.C., Shen J. Effect of acute psychological stress on prefrontal GABA concentration determined by proton magnetic resonance spectroscopy. American Journal of Psychiatry 2010, 167(10):1226-1231.
67. Herculano-Houzel S. Scaling of brain metabolism with a fixed energy budget per neuron: implications for neuronal activity, plasticity and evolution. PLoS ONE 2011, 6(3):e17514.
68. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., Cullinan W.E. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Frontiers in Neuroendocrinology 2003, 24:151-180.
69. Herman J.P., Ostrander M.M., Mueller N.K., Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2005, 29:1201-1213.
70. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Reviews 1996, 17:187-205.
71. Holsboer F., Gerken A., Steiger A., Benkert O., Muller O.A., Stalla G.K. Corticotropin-releasing-factor induced pituitary-adrenal response in depression. Lancet 1984, 1:55.
72. Homberg J.R., Lesch K.P. Looking on the bright side of serotonin transporter gene variation. Biological Psychiatry 2011, 69(6):513-519.
73. Hongpaisan J., Winters C.A., Andrews S.B. Strong calcium entry activates mitochondrial superoxide generation, upregulating kinase signaling in hippocampal neurons. Journal of Neuroscience 2004, 24(48):10878-10887.
74. Horvath R., Schoser B.G., Muller-Hocker J., Volpel M., Jaksch M., Lochmuller H. Mutations in mtDNA-encoded cytochrome c oxidase subunit genes causing isolated myopathy or severe encephalomyopathy. Neuromuscular Disorders 2005, 15:851-857.
75. Hroudova J., Fisar Z. Connectivity between mitochondrial functions and psychiatric disorders. Psychiatry and Clinical Neurosciences 2011, 65(2):130-141.
76. Hutchinson W.M. Clinical and molecular features of encephalomyopathie due to the A3301G mutation in the mitochondrial tRNA Leu (UUR) gene. Archives of Neurology 2005, 62:1220-1223.
77. Jacobs H., Smeitink J. Mitochondrial disease-the ever-widening circle. Biochimica et Biophysica Acta 2009, 1792:1095-1096.
78. Jaksch M., Lochmuller H., Schmitt F., Volpel B., Obermaier-Kusser B., Horvath R. A mutation in mt tRNALeu(UUR) causing a neuropsychiatric syndrome with depression and cataract. Neurology 2001, 57:1930-1931.
79. Joels M., Baram T.Z. The neuro-symphony of stress. Nature Reviews Neuroscience 2009, 10:459-466.
80. Joels M., Karst H., Derijk R., de Kloet E.R. The coming out of the brain mineralocorticoid receptor. Trends in Neurosciences 2008, 31:1-7.
81. Jou S.H., Chiu N.Y., Liu C.S. Mitochondrial dysfunction and psychiatric disorders. Chang Gung Medical Journal 2009, 32(4):370-379.
82. Kasahara T., Kubota M., Miyauchi T., Noda Y., Mouri A., Nabeshima T., Kato T. Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Molecular Psychiatry 2006, 11:577-593. 523.
83. Kasckow J.W., Baker D., Geracioti T.D. Corticotropin-releasing hormone in depression and post-traumatic stress disorder. Peptides 2001, 22:845-851.
84. Kato T. Molecular genetics of bipolar disorder and depression. Psychiatry and Clinical Neurosciences 2007, 61:3-19.
85. Keck M.E. Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Amino Acids 2006, 31:241-250.
86. Keen-Rhinehart E., Michopoulos V., Toufexis D.J., Martin E.I., Nair H., Ressler K.J., Davis M., Owens M.J., Nemeroff C.B., Wilson M.E. Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes. Molecular Psychiatry 2009, 14(1):37-50.
87. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., Wang P.S. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Journal of the American Medical Association 2003, 289:3095-3105.
88. Kirby D.M., Rennie K.J., Smulders-Srinivasan T.K., Acin-Perez R., Whittington M., Enriquez J.A., Trevelyan A.J., Turnbull D.M., Lightowlers R.N. Transmitochondrial embryonic stem cells containing pathogenic mtDNA mutations are compromised in neuronal differentiation. Cell Proliferation 2009, 42(4):413-424.
89. Kishida K.T., Klann E. Sources and targets of reactive oxygen species in synaptic plasticity and memory. Antioxidants and Redox Signalling 2007, 9(2):233-244.
90. Klann E. Cell-permeable scavengers of superoxide prevent long-term potentiation in hippocampal area CA1. Journal of Neurophysiology 1998, 80(1):452-457.
91. Klumpers U.M., Veltman D.J., Boellaard R., Comans E.F., Zuketto C., Yaqub M., Mourik J.E., Lubberink M., Hoogendijk W.J., Lammertsma A.A. Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies. Journal of Cerebral Blood Flow and Metabolism 2008, 28(3):579-587.
92. Knapman A., Kaltwasser S.F., Martins-de-Souza D., Holsboer F., Landgraf R., Turck C.W., Czisch M., Touma C. Increased stress reactivity is associated with reduced hippocampal activity and neuronal integrity along with changes in energy metabolism. European Journal of Neuroscience 2012, 35(3):412-422.
93. Knott A.B., Perkins G., Schwarzenbacher R., Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nature Reviews Neuroscience 2008, 9:505-518.
94. Kobayashi Y., Momoi M.Y., Tominaga K., Momoi T., Nihei K., Yanagisawa M., Kagawa Y., Ohta S. A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochemical and Biophysical Research Communications 1990, 173(3):816-822.
95. Koene S., Kozicz T.L., Rodenburg R.J., Verhaak C.M., de Vries M.C., Wortmann S., van de H.L., Smeitink J.A., Morava E. Major depression in adolescent children consecutively diagnosed with mitochondrial disorder. Journal of Affective Disorders 2009, 114:327-332.
96. Kondoh H., Lleonart M.E., Nakashima Y., Yokode M., Tanaka M., Bernard D., Gil J., Beach D. A high glycolytic flux supports the proliferative potential of murine embryonic stem cells. Antioxidants and Redox Signalling 2007, 9(3):293-299.
97. Koopman W.J., Willems P.H., Smeitink J.A. Monogenic mitochondrial disorders. New England Journal of Medicine 2012, 366(12):1132-1141.
98. Kovacs, M., 2002. Children's depression inventory (nederlands bewerking).
99. Kozicz T. Met-enkephalin immunoreactive neurons recruited by acute stress are innervated by axon terminals immunopositive for tyrosine hydroxylase and dopamine-alpha-hydroxylase in the anterolateral division of bed nuclei of the stria terminalis in the rat. European Journal of Neuroscience 2002, 16:823-835.
100. Kozicz T. On the role of urocortin 1 in the non-preganglionic Edinger-Westphal nucleus in stress adaptation. General and Comparative Endocrinology 2007, 153:235-240.
101. Kozicz T. Neurobiology of corticotropin releasing factor system components in stress; from adaptation to maladaptation. Neuropeptides and Peptide Analogs 2009, 59-90. Research Signpost, Kerala, India. M. Kovacs, I. Merchenthaler (Eds.).
102. Kozicz T., Vigh S., Arimura A. Immunohistochemical evidence for PACAP and VIP interaction with met-enkephalin and CRF containing neurons in the bed nucleus of the stria terminalis. Annals of the New York Academy of Sciences 1998, 865:523-528.
103. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., Laplant Q., Graham A., Lutter M., Lagace D.C., Ghose S., Reister R., Tannous P., Green T.A., Neve R.L., Chakravarty S., Kumar A., Eisch A.J., Self D.W., Lee F.S., Tamminga C.A., Cooper D.C., Gershenfeld H.K., Nestler E.J. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131(2):391-404.
104. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
105. Krishnan V., Nestler E.J. Linking molecules to mood: new insight into the biology of depression. American Journal of Psychiatry 2010, 167(11):1305-1320.
106. Kroenke K., Price R.K. Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Archives of Internal Medicine 1993, 153:2474-2480.
107. Kumar P., Kalonia H., Kumar A. Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study. Journal of Psychopharmacology 2011, 25(10):1399-1411.
108. Larsson N.G., Clayton D.A. Molecular genetic aspects of human mitochondrial disorders. Annual Review of Genetics 1995, 29:151-178.
109. Legros F., Malka F., Frachon P., Lombes A., Rojo M. Organization and dynamics of human mitochondrial DNA. Journal of Cell Science 2004, 117(Pt 13):2653-2662.
110. Li Y., Couch L., Higuchi M., Fang J.L., Guo L. Mitochondrial dysfunction induced by sertraline, an antidepressant agent. Toxicological Sciences 2012, 127(2):582-591.
111. Li Z., Ji G., Neugebauer V. Mitochondrial reactive oxygen species are activated by mGluR5 through IP3 and activate ERK and PKA to increase excitability of amygdala neurons and pain behavior. Journal of Neuroscience 2011, 31(3):1114-1127.
112. Li Z., Jo J., Jia J.M., Lo S.C., Whitcomb D.J., Jiao S., Cho K., Sheng M. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 2010, 141(5):859-871.
113. Liu R.T., Alloy L.B. Stress generation in depression: a systematic review of the empirical literature and recommendations for future study. Clinical Psychology Review 2010, 30(5):582-593.
114. Lopez A.D., Murray C.C. The global burden of disease, 1990-2020. Nature Medicine 1998, 4(11):1241-1243.
115. MacAskill A.F., Atkin T.A., Kittler J.T. Mitochondrial trafficking and the provision of energy and calcium buffering at excitatory synapses. European Journal of Neuroscience 2010, 32(2):231-240.
116. MacAskill A.F., Kittler J.T. Control of mitochondrial transport and localization in neurons. Trends in Cell Biology 2010, 20(2):102-112.
117. Manji H., Kato T., Di Prospero N.A., Ness S., Beal M.F., Krams M., Chen G. Impaired mitochondrial function in psychiatric disorders. Nature Reviews Neuroscience 2012, 13(5):293-307.
118. Marsden W.N. Stressor-induced NMDAR dysfunction as a unifying hypothesis for the aetiology, pathogenesis and comorbidity of clinical depression. Medical Hypotheses 2011, 77(4):508-528.
119. Martin E.I., Ressler K.J., Binder E., Nemeroff C.B. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Clinics in Laboratory Medicine 2010, 30(4):865-891.
120. Martinez M., Phillips P.J., Herbert J. Adaptation in patterns of c-fos expression in the brain associated with exposure to either single or repeated social stress in male rats. European Journal of Neuroscience 1998, 10(1):20-33.
121. Massaad C.A., Klann E. Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxidants and Redox Signalling 2011, 14(10):2013-2054.
122. Mattson M.P., Gleichmann M., Cheng A. Mitochondria in neuroplasticity and neurological disorders. Neuron 2008, 60:748-766.
123. Maurer I., Moller H.J. Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. Molecular and Cellular Biochemistry 1997, 174(1-2):255-259.
124. Maurer I.C., Schippel P., Volz H.P. Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue. Bipolar Disorders 2009, 11(5):515-522.
125. McEwen B.S. Stress, adaptation, and disease. Allostasis and allostatic load. Annals of the New York Academy of Sciences 1998, 840:33-44.
126. McEwen B.S. Mood disorders and allostatic load. Biological Psychiatry 2003, 54:200-207.
127. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiological Reviews 2007, 87:873-904.
128. McEwen B.S., Eiland L., Hunter R.G., Miller M.M. Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 2011.
129. McEwen B.S., Wingfield J.C. The concept of allostasis in biology and biomedicine. Hormones and Behavior 2003, 43:2-15.
130. Merchenthaler I., Vigh S., Petrusz P., Schally A.V. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. American Journal of Anatomy 1982, 165:385-396.
131. Miklos I.H., Kovacs K.J. Reorganization of synaptic inputs to the hypothalamic paraventricular nucleus during chronic psychogenic stress in rats. Biological Psychiatry 2012, 71(4):301-308.
132. Mody I., Maguire J. The reciprocal regulation of stress hormones and GABA(A) receptors. Frontiers in Cellular Neuroscience 2011, 6:4.
133. Moore C.M., Christensen J.D., Lafer B., Fava M., Renshaw P.F. Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study. American Journal of Psychiatry 1997, 154(1):116-118.
134. Morava E., Gardeitchik T., Kozicz T., de B.L., Koene S., de Vries M.C., McFarland R., Roobol T., Rodenburg R.J., Verhaak C.M. Depressive behaviour in children diagnosed with a mitochondrial disorder. Mitochondrion 2010, 10(5):528-533.
135. Morava E., Rodenburg R.J., Hol F., de V.M., Janssen A., van den Heuvel L., Nijtmans L., Smeitink J. Clinical and biochemical characteristics in patients with a high mutant load of the mitochondrial T8993G/C mutations. American Journal of Medical Genetics Part A 2006, 140(8):863-868.
136. Morava E., van den Heuvel L., Hol F., de Vries M.C., Hogeveen M., Rodenburg R.J., Smeitink J.A. Mitochondrial disease criteria: diagnostic applications in children. Neurology 2006, 67(10):1823-1826.
137. Morava E., van den H.L., Hol F., de Vries M.C., Hogeveen M., Rodenburg R.J., Smeitink J.A. Mitochondrial disease criteria: diagnostic applications in children. Neurology 2006, 67:1823-1826.
138. Mueller B.R., Bale T.L. Impact of prenatal stress on long term body weight is dependent on timing and maternal sensitivity. Physiology and Behavior 2006, 88:605-614.
139. Munakata K., Fujii K., Nanko S., Kunugi H., Kato T. Sequence and functional analyses of mtDNA in a maternally inherited family with bipolar disorder and depression. Mutation Research 2007, 617:119-124.
140. Munakata K., Iwamoto K., Bundo M., Kato T. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biological Psychiatry 2005, 57:525-532.
141. Munakata K., Tanaka M., Mori K., Washizuka S., Yoneda M., Tajima O., Akiyama T., Nanko S., Kunugi H., Tadokoro K., Ozaki N., Inada T., Sakamoto K., Fukunaga T., Iijima Y., Iwata N., Tatsumi M., Yamada K., Yoshikawa T., Kato T. Mitochondrial DNA 3644T-->C mutation associated with bipolar disorder. Genomics 2004, 84:1041-1050.
142. Myers B., McKlveen J.M., Herman J.P. Neural regulation of the stress response: the many faces of feedback. Cellular and Molecular Neurobiology 2012, [Epub ahead of print] PMID: 22302180.
143. Nederhof E., Schmidt M.V. Mismatch or cumulative stress: toward an integrated hypothesis of programming effects. Physiology and Behavior 2012, 106(5):691-700.
144. Nemeroff C.B. The role of corticotropin-releasing factor in the pathogenesis of major depression. Pharmacopsychiatry 1988, 21:76-82.
145. Nemeroff C.B. New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor. Neuropsychopharmacology 1992, 6:69-75.
146. Nemeroff C.B., Vale W.W. The neurobiology of depression: inroads to treatment and new drug discovery. Journal of Clinical Psychiatry 2005, 66(Suppl. 7):5-13.
147. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984, 226:1342-1344.
148. Nestler E.J. Epigenetic mechanisms in psychiatry. Biological Psychiatry 2009, 65:189-190.
149. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nature Neuroscience 2010, 13(10):1161-1169.
150. Neustadt J., Pieczenik S.R. Medication-induced mitochondrial damage and disease. Molecular Nutrition and Food Research 2008, 52(7):780-788.
151. Onishi H., Kawanishi C., Iwasawa T., Osaka H., Hanihara T., Inoue K., Yamada Y., Kosaka K. Depressive disorder due to mitochondrial transfer RNALeu(UUR) mutation. Biological Psychiatry 1997, 41:1137-1139.
152. Pincus H.A., Pettit A.R. The societal costs of chronic major depression. Journal of Clinical Psychiatry 2001, 62(Suppl. 6):5-9.
153. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33(1):88-109.
154. Pivovarova N.B., Pozzo-Miller L.D., Hongpaisan J., Andrews S.B. Correlated calcium uptake and release by mitochondria and endoplasmic reticulum of CA3 hippocampal dendrites after afferent synaptic stimulation. Journal of Neuroscience 2002, 22(24):10653-10661.
155. Plotsky P.M., Owens M.J., Nemeroff C.B. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatric Clinics of North America 1998, 21:293-307.
156. Price J.L., Drevets W.C. Neural circuits underlying the pathophysiology of mood disorders. Trends in Cognitive Sciences 2012, 16(1):61-71.
157. Prigione A., Fauler B., Lurz R., Lehrach H., Adjaye J. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 2010, 28(4):721-733.
158. Quintana A., Kruse S.E., Kapur R.P., Sanz E., Palmiter R.D. Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:10996-11001.
159. Raadsheer F.C., Hoogendijk W.J., Stam F.C., Tilders F.J., Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994, 60:436-444.
160. Raadsheer F.C., van Heerikhuize J.J., Lucassen P.J., Hoogendijk W.J., Tilders F.J., Swaab D.F. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. American Journal of Psychiatry 1995, 152:1372-1376.
161. Radley J.J., Kabbaj M., Jacobson L., Heydendael W., Yehuda R., Herman J.P. Stress risk factors and stress-related pathology: neuroplasticity, epigenetics and endophenotypes. Stress 2011, 14(5):481-497.
162. Refojo D., Schweizer M., Kuehne C., Ehrenberg S., Thoeringer C., Vogl A.M., Dedic N., Schumacher M., von W.G., Avrabos C., Touma C., Engblom D., Schutz G., Nave K.A., Eder M., Wotjak C.T., Sillaber I., Holsboer F., Wurst W., Deussing J.M. Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science 2011, 333(6051):1903-1907.
163. Regev L., Neufeld-Cohen A., Tsoory M., Kuperman Y., Getselter D., Gil S., Chen A. Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation. Molecular Psychiatry 2011, 16:714-728.
164. Renthal W., Nestler E.J. Chromatin regulation in drug addiction and depression. Dialogues in Clinical Neuroscience 2009, 11(3):257-268.
165. Reul J.M., Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Current Opinion in Pharmacology 2002, 2:23-33.
166. Rezin G.T., Amboni G., Zugno A.I., Quevedo J., Streck E.L. Mitochondrial dysfunction and psychiatric disorders. Neurochemical Research 2009, 34:1021-1029.
167. Rezin G.T., Cardoso M.R., Goncalves C.L., Scaini G., Fraga D.B., Riegel R.E., Comim C.M., Quevedo J., Streck E.L. Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochemistry International 2008, 53:395-400.
168. Rollins B., Martin M.V., Sequeira P.A., Moon E.A., Morgan L.Z., Watson S.J., Schatzberg A., Akil H., Myers R.M., Jones E.G., Wallace D.C., Bunney W.E., Vawter M.P. Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS ONE 2009, 4:e4913.
169. Roozendaal B., McEwen B.S., Chattarji S. Stress, memory and the amygdala. Nature Reviews Neuroscience 2009, 10(6):423-433.
170. Rouwette T., Klemann K., Gaszner B., Scheffer G.J., Roubos E.W., Scheenen W.J., Vissers K., Kozicz T. Differential responses of corticotropin-releasing factor and urocortin 1 to acute pain stress in the rat brain. Neuroscience 2011, 183:15-24.
171. Rouwette T.P., Kozicz T., Olde Loohuis N.F., Gaszner B., Vreugdenhil E., Scheffer G.J., Roubos E.W., Vissers K.C., Scheenen W.J. Acute pain increases phosphorylation of DCLK-long in the Edinger-Westphal nucleus but not in the hypothalamic paraventricular nucleus of the rat. Journal of Pain 2010, 11(10):930-940.
172. Rubin R.T., Poland R.E., Lesser I.M., Winston R.A., Blodgett A.L. Neuroendocrine aspects of primary endogenous depression, I. Cortisol secretory dynamics in patients and matched controls. Archives of General Psychiatry 1987, 44:328-336.
173. Samuels B.A., Hen R. Neurogenesis and affective disorders. European Journal of Neuroscience 2011, 33(6):1152-1159.
174. Scaini G., Maggi D.D., De-Nes B.T., Goncalves C.L., Ferreira G.T., Teodorak B.P., Bez G.D., Ferreira G.C., Schuck P.F., Quevedo J., Streck E.L. Activity of mitochondrial respiratory chain is increased by chronic administration of antidepressants. Acta Neurophysiologica 2011, 23:112-118.
175. Scaini G., Santos P.M., Benedet J., Rochi N., Gomes L.M., Borges L.S., Rezin G.T., Pezente D.P., Quevedo J., Streck E.L. Evaluation of Krebs cycle enzymes in the brain of rats after chronic administration of antidepressants. Brain Research Bulletin 2010, 82(3-4):224-227.
176. Schmidt M.V. Animal models for depression and the mismatch hypothesis of disease. Psychoneuroendocrinology 2011, 36(3):330-338.
177. Schmidt M.V., Sterlemann V., Ganea K., Liebl C., Alam S., Harbich D., Greetfeld M., Uhr M., Holsboer F., Muller M.B. Persistent neuroendocrine and behavioral effects of a novel, etiologically relevant mouse paradigm for chronic social stress during adolescence. Psychoneuroendocrinology 2007, 32(5):417-429.
178. Schmidt M.V., Sterlemann V., Muller M.B. Chronic stress and individual vulnerability. Annals of the New York Academy of Sciences 2008, 1148:174-183.
179. Selye H. The general adaptation syndrome and the diseases of adaptation. Journal of Clinical Endocrinology and Metabolism 1946, 6:117-230.
180. Seo A.Y., Joseph A.M., Dutta D., Hwang J.C., Aris J.P., Leeuwenburgh C. New insights into the role of mitochondria in aging: mitochondrial dynamics and more. Journal of Cell Science 2010, 123(Pt 15):2533-2542.
181. Sequeira A., Martin M.V., Rollins B., Moon E.A., Bunney W.E., Macciardi F., Lupoli S., Smith E.N., Kelsoe J., Magnan C.N., van O.M., Baldi P., Wallace D.C., Vawter M.P. Mitochondrial mutations and polymorphisms in psychiatric disorders. Frontiers in Genetics 2012, 3:103.
182. Shalbuyeva N., Brustovetsky T., Brustovetsky N. Lithium desensitizes brain mitochondria to calcium, antagonizes permeability transition, and diminishes cytochrome C release. Journal of Biological Chemistry 2007, 282(25):18057-18068.
183. Shanske S., Pancrudo J., Kaufmann P., Engelstad K., Jhung S., Lu J., Naini A., DiMauro S., De Vivo D.C. Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis. American Journal of Medical Genetics Part A 2004, 130A(2):134-137.
184. Shao L., Martin M.V., Watson S.J., Schatzberg A., Akil H., Myers R.M., Jones E.G., Bunney W.E., Vawter M.P. Mitochondrial involvement in psychiatric disorders. Annals of Medicine 2008, 40:281-295.
185. Shin S.Y., Han T.H., Lee S.Y., Han S.K., Park J.B., Erdelyi F., Szabo G., Ryu P.D. Direct corticosteroid modulation of GABAergic neurons in the anterior hypothalamic area of GAD65-eGFP mice. Korean Journal of Physiology and Pharmacology 2011, 15(3):163-169.
186. Smeitink J.A., Zeviani M., Turnbull D.M., Jacobs H.T. Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metabolism 2006, 3:9-13.
187. Sterling P., Eyer J. Allostasis: a new paradigm to explain arousal pathology. Handbook of Life Stress 1988, 629-649. John Wiley & Sons, New York. S. Fisher, J. Reason (Eds.).
188. Sterrenburg L., Borch A., Peeters B.W., Pinter O., Zelena D., Roubos E.W., Kozicz T. Acute ether stress differentially affects corticotropin-releasing factor and urocortin 1 in the Brattleboro rat. Brain Research 2011, 1398:21-29.
189. Strohle A., Holsboer F. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 2003, 36(Suppl. 3):S207-S214.
190. Suomalainen A., Majander A., Haltia M., Somer H., Lonnqvist J., Savontaus M.L., Peltonen L. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. Journal of Clinical Investigation 1992, 90(1):61-66.
191. Swanson L.W., Petrovich G.D. What is the amygdala?. Trends in Neurosciences 1998, 21:323-331.
192. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983, 36(3):165-186.
193. Tsigos C., Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. Journal of Psychosomatic Research 2002, 53:865-871.
194. Ulrich-Lai Y.M., Herman J.P. Neural regulation of endocrine and autonomic stress responses. Nature Reviews Neuroscience 2009, 10(6):397-409.
195. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213:1394-1397.
196. van den Ouweland J.M., de Klerk J.B., van de Corp, Dirks R.W., Raap A.K., Scholte H.R., Huijmans J.G., Hart L.M., Bruining G.J., Maassen J.A. Characterization of a novel mitochondrial DNA deletion in a patient with a variant of the Pearson marrow-pancreas syndrome. European Journal of Human Genetics 2000, 8:195-203.
197. Vayssiere J.L., Cordeau-Lossouarn L., Larcher J.C., Basseville M., Gros F., Croizat B. Participation of the mitochondrial genome in the differentiation of neuroblastoma cells. In Vitro Cellular and Developmental Biology 1992, 28A(11-12):763-772.
198. Verhulst F.C., van der E.J., Ferdinand R.F., Kasius M.C. The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents. Archives of General Psychiatry 1997, 54:329-336.
199. Verkuyl J.M., Joels M. Effect of adrenalectomy on miniature inhibitory postsynaptic currents in the paraventricular nucleus of the hypothalamus. Journal of Neurophysiology 2003, 89(1):237-245.
200. Verkuyl J.M., Karst H., Joels M. GABAergic transmission in the rat paraventricular nucleus of the hypothalamus is suppressed by corticosterone and stress. European Journal of Neuroscience 2005, 21(1):113-121.
201. Wallace D.C., Fan W. The pathophysiology of mitochondrial disease as modeled in the mouse. Genes and Development 2009, 23(15):1714-1736.
202. Wallace D.C., Fan W. Energetics, epigenetics, mitochondrial genetics. Mitochondrion 2010, 10(1):12-31.
203. Wallace D.C., Fan W., Procaccio V. Mitochondrial energetics and therapeutics. Annual Review of Pathology 2010, 5:297-348.
204. Wallace D.C., Singh G., Lott M.T., Hodge J.A., Schurr T.G., Lezza A.M., Elsas L.J., Nikoskelainen E.K. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988, 242(4884):1427-1430.
205. Weinbach E.C., Costa J.L., Claggett C.E., Fay D.D., Hundal T. Reserpine as an uncoupler of oxidative phosphorylation and the relevance to its psychoactive properties. Biochemical Pharmacology 1983, 32(8):1371-1377.
206. Weintraub D., Stern M.B. Psychiatric complications in Parkinson disease. American Journal of Geriatric Psychiatry 2005, 13(10):844-851.
207. Wittchen H.U., Jacobi F. Size and burden of mental disorders in Europe-a critical review and appraisal of 27 studies. European Neuropsychopharmacology 2005, 15(4):357-376.
208. Wittchen H.U., Jonsson B., Olesen J. Towards a better understanding of the size and burden and cost of brain disorders in Europe. European Neuropsychopharmacology 2005, 15:355-356.
209. Wortmann S.B., Rodenburg R.J., Jonckheere A., de Vries M.C., Huizing M., Heldt K., van den Heuvel L.P., Wendel U., Kluijtmans L.A., Engelke U.F., Wevers R.A., Smeitink J.A., Morava E. Biochemical and genetic analysis of 3-methylglutaconic aciduria type IV: a diagnostic strategy. Brain 2009, 132(Pt 1):136-146.
210. Yehuda R., Seckl J. Minireview: stress-related psychiatric disorders with low cortisol levels: a metabolic hypothesis. Endocrinology 2011, 152(12):4496-4503.
211. Yu Y.W., Tsai S.J., Hong C.J., Chen T.J., Chen M.C., Yang C.W. Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology 2005, 30:1719-1723.
212. Zeviani M., Di D.S. Mitochondrial disorders. Brain 2004, 127(Pt 10):2153-2172.
213. Zhang W.H., Wang H., Wang X., Narayanan M.V., Stavrovskaya I.G., Kristal B.S., Friedlander R.M. Nortriptyline protects mitochondria and reduces cerebral ischemia/hypoxia injury. Stroke 2008, 39(2):455-462.